Human GLP-1 (7-37)

We are Human GLP-1 (7-37) CAS:106612-94-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Human GLP-1 (7-37)
CAS.NO:106612-94-6
Synonyms:Human GLP-1 (7-37)
GLP-1 (7-37) Acetate
GLP-1(7-37)
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Molecular Formula C151H228N40O47
Molecular Weight 3355.666
Index of Refraction 1.660
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:GLP-1 (7-37) acetate augments glucose-induced insulin secretion and simultaneously inhibits glucagon secretion and gastric emptying.

Human GLP-1 (7-37)


Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.4-hidroxipiperidina-1-carboxilato de etilo CAS:65214-82-6 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.DL-Glutamic Acid CAS:617-65-2 The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.2'-desoxiadenosina CAS:958-09-8 AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.

Related Products
Product Name
N-Phenylglycine View Details
3-Amino-5-mercapto-1,2,4-triazole View Details
Dimethylthiophosphinoyl Chloride View Details
Ethyl 4-amino-1-piperidinecarboxylate manufacturer 1-Chloro-2-fluoro-3-isocyanatobenzene manufacturer N-(Triphenylmethyl)-5-(4-Bromomethylbiphenyl-2-yl-)Tetrazole manufacturer 4,4′-Diaminodiphenylsulfone manufacturer 1-Phenyl-1,2,3,4-tetrahydroisoquinoline manufacturer